Live data from Hacker News

Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes

nbcnews.com

11–20 of 214 posts

Re: Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes

#11
> nationwide database of electronic health records (EHRs) of 116 million US patients.

If you are expert in this space: Is such a dataset available publicly? If so, are there examples of other studies that have used this? Where does one go to read more about the mechanism of this study? Thanks!

Re: Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes

#12

How do you isolate this from the therapeutic benefits of simply losing weight and being skinny?

There are multiple confounding factors:

* Blood sugar levels (or whatever this is a proxy for)

* Weight

* The changes the GLP-1 Agonists make to the body itself.

While it is simple to say if you reduce the weight, you reduce the blood sugar levels, and so the GLP-1 is unnecessary, you can look at many accounts of using Ozempic where it talks about reducing the "food noise."

That is, Ozempic makes it easier to eat the right things. I'm a "normal weight" through grit, but I don't think my life is better through said grit - in fact, I'd say it's significantly worse. In my earlier life, I was naturally thin, and I can say that my weight increase wasn't a significant change to my diet, nor was my weight loss: I just had to be hungry and irritable more.

So, fundamentally, the cause and effect doesn't matter, because the drug makes it easier to be a more healthy weight and to control the blood sugar.

Re: Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes

#13

How do you isolate this from the therapeutic benefits of simply losing weight and being skinny?

Another interesting point from the study (full paper linked in a other comment) was the comparison of semaglutide to other GLP-1 agonists taken by patients, with the impact being significantly higher vs. those.

Obviously we need some more double blind studies dedicated to this class of drugs and Alzheimer's, but this informs the direction researchers and drug companies will likely map out.

Re: Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes

#14

How do you isolate this from the therapeutic benefits of simply losing weight and being skinny?

There are multiple confounding factors: * Blood sugar levels (or whatever this is a proxy for) * Weight * The changes the GLP-1 Agonists make to the body itself. While it is simple to say if you reduce the weight, you reduce the blood sugar levels, and so the GLP-1 is unnecessary, you can look at many accounts of using Ozempic where it talks about reducing the "food noise." That is, Ozempic makes it easier to eat the…

> nor was my weight loss: I just had to be hungry and irritable more

Yes! I keep trying to explain to folks that this is the benefit of these drugs, they let you keep a healthy relationship with food, maintain "intuitive eating" where you aren't constantly fighting and discarding your hunger signals, and aren't (as) miserable doing it.

I did it the hard way, I wouldn't wish it on anyone.

Re: Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes

#15

TL;DR from the article: The study found that patients prescribed semaglutide had a significantly lower risk for Alzheimer’s disease than those who had taken one of the seven other diabetes drugs. The results were consistent across gender, age and weight. The biggest difference was seen when comparing patients who took semaglutide to those who took insulin: Semaglutide patients had a 70% lower risk of Alzheimer’s, the…

With the constant stream of positive news around GLP-1s, and ever-growing list of things they treat, we may all wind up on some dose with only the dose varying depending on what illness they're targeting.

[deleted]

Re: Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes

#16

> nationwide database of electronic health records (EHRs) of 116 million US patients. If you are expert in this space: Is such a dataset available publicly? If so, are there examples of other studies that have used this? Where does one go to read more about the mechanism of this study? Thanks!

There is no public dataset of EHRs of this size.

Re: Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes

#17

> nationwide database of electronic health records (EHRs) of 116 million US patients. If you are expert in this space: Is such a dataset available publicly? If so, are there examples of other studies that have used this? Where does one go to read more about the mechanism of this study? Thanks!

Almost all health datasets are not public

Re: Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes

#19

Of all things my taxes go to, I would love it the United States Government would buy the patent for this drug and make it freely available to anybody who wants it. The number of things it apparently just cures is staggering.

Gonna be fun discovering what side effects it causes in 20 years tho.

Re: Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes

#20

Earlier quoted context omitted.

With the constant stream of positive news around GLP-1s, and ever-growing list of things they treat, we may all wind up on some dose with only the dose varying depending on what illness they're targeting.

My PCP agrees that the great results I'm getting on Fen-Phen mean I won't need to switch!

GLP-1 have already been on the mass market longer than Fen-Phen (7-years for Fen-Phen Vs. 15+ years, even just Semaglutide has been available longer than Fen-Phen now, and Semaglutide is a third-gen GLP-1).

Honestly, this retort can be made about any/all new drugs entering the market. If you had a legitimate retort/critique I'm sure you would have presented it, but this is all we get.

This is what happens when you start out with "[thing] is bad" then work backwards to figure out a reason.

Post reply on HN